[go: up one dir, main page]

WO2007116863A1 - Système d'injection de médicament liquide - Google Patents

Système d'injection de médicament liquide Download PDF

Info

Publication number
WO2007116863A1
WO2007116863A1 PCT/JP2007/057411 JP2007057411W WO2007116863A1 WO 2007116863 A1 WO2007116863 A1 WO 2007116863A1 JP 2007057411 W JP2007057411 W JP 2007057411W WO 2007116863 A1 WO2007116863 A1 WO 2007116863A1
Authority
WO
WIPO (PCT)
Prior art keywords
chemical
cylinder
syringe
rfid tag
holding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2007/057411
Other languages
English (en)
Japanese (ja)
Inventor
Shigeru Nemoto
Masahiro Sakakibara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nemoto Kyorindo Co Ltd
Original Assignee
Nemoto Kyorindo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemoto Kyorindo Co Ltd filed Critical Nemoto Kyorindo Co Ltd
Priority to JP2008509836A priority Critical patent/JP5063591B2/ja
Publication of WO2007116863A1 publication Critical patent/WO2007116863A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14546Front-loading type injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3569Range sublocal, e.g. between console and disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6054Magnetic identification systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir

Definitions

  • the present invention relates to a chemical solution injection system for injecting a chemical solution of a chemical solution syringe into a subject with a chemical solution injection device.
  • the present invention relates to a chemical injection system that injects a contrast medium into a subject whose fluoroscopic image is captured by a fluoroscopic imaging device such as a scanner.
  • a fluoroscopic imaging device for imaging a fluoroscopic image of a subject
  • a CT scanner an MRI (Magnetic Resonance Imaging) device
  • MRI Magnetic Resonance Imaging
  • PET PET
  • ultrasonic diagnostic device a CT angiography device
  • MRA MRA
  • Angio equipment, etc.
  • a chemical solution such as a contrast medium or physiological saline may be injected into the subject, and a chemical injection device that automatically performs this injection has also been put into practical use! .
  • Such a chemical solution injection device has, for example, a piston drive mechanism including a drive motor and a slider mechanism, and a chemical solution syringe is detachably attached thereto.
  • the chemical syringe generally has a cylinder member and a piston member, and the piston member is slidably inserted into the cylinder member.
  • the cylinder member has a cylindrical cylinder body, and a conduit portion is formed at the center of the closed front end.
  • the rear end of the cylinder body is opened, and a piston member is inserted into the inside through the opening.
  • An annular cylinder flange is formed on the outer periphery of the rear end of the cylinder body.
  • Such a liquid syringe includes a prefilled type and a post-filling type.
  • the pre-filled type is shipped with the cylinder member filled with chemicals and sealed entirely with packing material.
  • a post-filling type a cylinder member is filled with a desired chemical solution by a user.
  • the chemical syringe is a prefilled type.
  • the chemical injection device press-fits the piston member into the cylinder member by the piston drive mechanism in response to a predetermined operation.
  • the drug solution is injected into the subject by the drug syringe force.
  • the chemical solution injection device supplies the chemical solution corresponding to the input data. Inject the subject. For example, if a contrast medium is injected as a chemical solution, the contrast level of the subject changes, and a good fluoroscopic image is captured by the fluoroscopic imaging device.
  • a force chemical liquid injection device having a high viscosity contrast medium is suitable for injecting a contrast medium because a piston member can be pushed into a cylinder member of a chemical liquid syringe at a high pressure.
  • a piston member can be pushed into a cylinder member of a chemical liquid syringe at a high pressure.
  • the chemical injection device implemented by the present applicant has a pair of left and right metal flange holding members, and the flange holding member can be freely opened and closed by the metal main body holding member. I support it.
  • the main body holding member has a holding recess formed on the upper surface, and holds the cylinder main body inserted from the upper side by the holding recess.
  • the pair of left and right flange holding members are formed with holding slits on the inner surfaces facing each other, and hold the left and right portions of the cylinder flange of the chemical syringe inserted from above in an open state in a closed state.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2004-154238
  • Patent Document 2 JP 2004-154239 A
  • Patent Document 3 JP 2004-187849
  • Patent Document 4 Japanese Patent Application Laid-Open No. 2004-243009
  • Patent Document 5 Japanese Patent Application Laid-Open No. 2004-290454
  • the cylinder flange of the chemical syringe can be firmly held by the metal flange holding member. Therefore, a high viscosity contrast agent is formed by pushing the piston member into the cylinder member of the chemical syringe at a high pressure. Can be successfully injected into a subject. Moreover, since the flange holding member that can be opened and closed is supported by the metal main body holding member, even if a large amount of stress acts on the chemical liquid syringe force flange holding member, for example, the main body holding member may be deformed or damaged. Don't do it.
  • a flat portion is formed on a part of the outer peripheral surface of the cylinder flange in order to prevent unnecessary rolling and the like.
  • the flat portion is usually formed in a shape obtained by partially cutting the circular outer peripheral surface of the cylinder flange in a straight line, and is formed in parallel so as to be paired with the opposite position of the outer peripheral surface of the cylinder flange. ing. Therefore, the above-described chemical injection device is configured to hold a circular portion, which is not a flat portion of the cylinder flange, with a flange holding member. Therefore, the operator needs to hold the cylinder flange on the flange holding member at the position of the circular portion.
  • the present applicant's power application 2004-110853 (WO2005Z097232A1)
  • a pattern that has a predetermined shape when viewed from above through a cylinder member filled with a transparent chemical solution is formed on the lower surface of the cylinder member and the inner surface of the holding recess of the main body holding member. It is divided into two.
  • the upward force of the cylinder member is visually recognized as a predetermined shape only when the chemical solution syringe filled with the chemical solution is properly attached to the chemical solution injection device.
  • this visual recognition it is possible to confirm both that the chemical syringe is appropriately held and that the cylinder member is filled with the chemical solution at a time.
  • the chemical solution is injected into the subject from the chemical solution syringe.
  • the operator needs to select an appropriate chemical solution syringe. is there.
  • the operator since there are products with the same or similar appearance even if the type of the chemical solution is different, there is a possibility that the operator may attach the chemical syringe of the chemical solution to the chemical injection device.
  • a product that is not a compatible product may be used as a chemical syringe, and a medical accident may occur due to inadequate performance such as pressure resistance.
  • prefilled type drug syringes are discarded after a single use in order to prevent infection, but current drug injectors cannot prevent a drug syringe once used from being used again. .
  • the present invention has been made in view of the above-described problems, and the flange holding member appropriately holds the chemical syringe, and automatically prevents the piston drive mechanism from being driven in this state.
  • An object of the present invention is to provide a chemical solution injection system that can be used.
  • the chemical solution injection system of the present invention includes a chemical solution syringe and a chemical solution injection device.
  • the chemical syringe includes a cylinder member having a cylinder flange formed on the outer periphery of the rear end of the cylinder body, and a piston member that is slidably inserted into the cylinder member in a backward direction.
  • the chemical injection device pushes the piston member into the cylinder member of the chemical syringe and injects the chemical into the subject.
  • the chemical syringe has an RFID tag mounted on the outer peripheral surface of the cylinder body.
  • the RFID tag has a circuit chip and a planar loop antenna connected to the circuit chip, and wirelessly transmits recording data by electromagnetic induction.
  • the chemical liquid injector includes a main body holding member, a flange holding member, a piston drive mechanism, an RFID reader, an operation control means, and an antenna sheet.
  • the main body holding member is made of metal, and holds the cylinder main body inserted from above by the holding recess.
  • the flange holding member is made of metal and supported by the main body holding member, and holds the cylinder flange inserted from the upper side.
  • the piston drive mechanism pushes the piston member into the cylinder member held together with the cylinder flange.
  • the RFID reader wirelessly receives the RFID tag recording data by electromagnetic induction.
  • the operation control means controls the operation of the piston drive mechanism in response to the wireless reception of the recording data.
  • the antenna sheet has an elongated loop antenna.
  • a through hole is formed in the main body holding member from the outer surface to the inner surface of the holding recess.
  • the RFID reader is arranged at a position adjacent to the through hole on the outer surface of the holding recess.
  • One end of the antenna sheet passed through the through hole of the holding recess is disposed on the inner surface of the holding recess, and the other end faces the RFID reader.
  • the RFID tag is parallel to one end of the antenna sheet by properly attaching the chemical syringe to the chemical injection device. It can be made to face.
  • the RFID tag and the antenna sheet as described above can be formed in a substantially rectangular sheet shape, for example.
  • the antenna sheet can be formed as a structure corresponding to an R FID tag in which the circuit chip is omitted.
  • RFID tags and antenna sheets are approved as communication devices of the unified standard and are mass-produced as off-the-shelf products.
  • the RFID tag can be made to face the one end of the antenna sheet in parallel by appropriately attaching the chemical syringe to the chemical injection device. It is possible to easily and reliably detect whether a chemical syringe is properly attached to the chemical injection device using the existing antenna sheet.
  • the various means referred to in the present invention are preferably provided so as to realize their functions.
  • dedicated hardware that exhibits a predetermined function and a predetermined function are given by a computer program.
  • the data processing device, a predetermined function implemented in the data processing device by a computer program, a combination thereof, and the like can be realized.
  • a plurality of constituent elements that do not need to be independent from each other are formed as one member, and one constituent element includes a plurality of members. It is possible that a component is a part of another component, a part of a component overlaps a part of another component, etc. is there.
  • the front-rear direction and the up-down direction are defined, but this is defined for convenience in order to briefly explain the relative relationship of the constituent elements of the present invention. It does not limit the direction of production or use when it is implemented.
  • the one end, the other end, the left end, and the right end of the antenna sheet referred to in the present invention mean a portion from the outermost edge in the longitudinal direction to an arbitrary range, such as a substantially square portion. Good.
  • FIG. 1 is a schematic longitudinal side view of a main part showing a state in which a chemical syringe is attached to an injection head of a chemical injection device according to an embodiment of the present invention.
  • FIG. 2 is a perspective view showing a state in which a chemical syringe is attached to an injection head.
  • ⁇ 3] It is a perspective view showing the appearance of the chemical liquid injector.
  • FIG. 5 is a block diagram showing a circuit structure of the chemical solution injection system.
  • FIG. 6 is a perspective view showing an appearance of a chemical syringe.
  • FIG. 7 is a schematic perspective view showing the appearance of the RFID tag.
  • FIG. 8 is a schematic front view of the main part showing a state in which the chemical syringe is attached to the injection head.
  • FIG. 9 is a block diagram showing a logical structure of the chemical liquid injector.
  • FIG. 10 is a flowchart showing the first half of the processing operation of the chemical liquid injector.
  • FIG. 11 is a flowchart showing the latter half of the processing operation of the chemical injection device.
  • FIG. 12 is a flowchart showing the processing operation of the CT scanner.
  • FIG. 13 is a perspective view showing a modification of the injection head.
  • the chemical injection system 1000 of this embodiment includes a chemical injection device 100, a chemical syringe 200, and a CT scanner 300 that is a fluoroscopic imaging device. As will be described later, a fluoroscopic image is taken from a subject (not shown) who injects a medical solution such as a contrast medium.
  • the CT scanner 300 includes a fluoroscopic imaging unit 301 and an imaging control unit 302, as shown in FIGS.
  • the fluoroscopic imaging unit 301 and the imaging control unit 302 are wiredly connected via a communication network 303.
  • the fluoroscopic imaging unit 301 captures a fluoroscopic image from the subject, and the imaging control unit 302 controls the operation of the fluoroscopic imaging unit 301.
  • the chemical syringe 200 has a cylinder member 210 and a piston member 220, and the piston member 220 is slidably inserted into the cylinder member 210.
  • the cylinder member 210 has a cylindrical cylinder body 211, and a conduit portion 212 is formed at the closed front end of the cylinder body 211.
  • the rear end of the cylinder body 211 of the cylinder member 210 is opened, and the piston member 220 is inserted into the cylinder body 211 from this opening.
  • the cylinder member 210 has an annular cylinder flange 213 formed on the outer periphery of the rear end of the cylinder body 211, and the piston member 220 is an annular piston formed on the outer periphery of the piston body 221. It has flange 222.
  • the cylinder member 210 is formed of a non-conductive and non-magnetic resin, and has a thickness of about 1.5 mm to 2.0 mm, for example.
  • the chemical solution injection system 1000 of this embodiment at least a part of the chemical solution syringe 200 used is a prefilled type.
  • the pre-filled type chemical solution syringe 200 is shipped with the cylinder member 210 filled with the chemical solution.
  • the RFID tag 230 is attached to the cylinder member 210 of the chemical syringe 200.
  • the RFID tag 230 includes the name, prefilled type force refilter identification data, identification data for each individual, capacity, cylinder member 210 pressure resistance, cylinder member 210 inner diameter, and piston member 220 stroke. Various data such as, etc. are recorded.
  • the RFID tag 230 has a name, component, viscosity, expiration date, identification data such as whether it is for CT or MR, etc. Various data are also recorded. Further, when the drug solution filled in the prefilled type drug solution syringe 200 is a contrast medium, a variable pattern that changes the injection rate with time is recorded in the RFID tag 230 as necessary.
  • the RFID tag 230 has a long and narrow resin sheet 231, and a circuit chip 232 is enclosed in the vicinity of one end thereof.
  • the tag antenna 233 is also formed on the resin sheet 231 by a printed wiring as a planar and elongated loop antenna. It is.
  • the tag antenna 233 is connected to the circuit chip 232.
  • the surface of the resin sheet 231 is formed in white, and various information can be printed on this surface.
  • An adhesive material (not shown) is applied to the back surface of the resin sheet 231, and the RFID tag 230 can be attached to the outer peripheral surface of the cylinder member 210 with the adhesive material.
  • the chemical syringe 200 has a pair of flat portions 215 formed in parallel at opposite positions of the circular outer peripheral surface 214 of the cylinder flange 213.
  • the cylinder flange 213 has a left-right symmetry and a vertically symmetrical structure.
  • this chemical syringe 200 has, for example, a sticker with a message such as "Please use this as the upper side” or "Do not use this as the upper side”.
  • a sticker with a message such as "Please use this as the upper side” or "Do not use this as the upper side”.
  • the RFID tag 230 has a longitudinal direction parallel to the axial direction of the cylinder member 210, and the bottom of the cylinder body 211. It is mounted on the outer peripheral surface.
  • the drug solution injection device 100 of the present embodiment includes an injection head 110 and an injection control unit 101 that are configured separately from each other and are wire-connected by a communication cable 102.
  • the injection head 110 drives the chemical solution syringe 200 to be attached to inject the chemical solution into the subject.
  • the injection control unit 101 controls the operation of the injection head 110.
  • the injection head 110 is attached to the upper end of the caster stand 111 via the movable arm 112, and as shown in FIG.
  • the injection head 110 has a head housing 113 as an exterior.
  • the head housing 113 is entirely formed of a resin, but as shown in FIGS. 1 and 2, only the upper part of the front end is formed of a metal main body holding member 114.
  • the main body holding member 114 is formed of a high-strength nonmagnetic metal such as an aluminum alloy, and has a semi-cylindrical shape that holds the cylinder main body 211 inserted from the upper side.
  • the holding recess 115 is formed on the upper surface.
  • a cylinder holding mechanism 120 is disposed at the rear end of the main body holding member 114. Cylinder holding mechanism 120 is stainless steel alloy etc. It is made of high strength metal.
  • This cylinder holding mechanism 120 has a pair of left and right flange holding members 121.
  • the pair of left and right flange holding members 121 includes a fixed holding member 122 and a movable holding member 123.
  • the fixed holding member 122 is fixed to the rear end of the main body holding member 114, and the movable holding member 123 is supported by the rear end of the main body holding member 114 so as to be opened and closed in the left-right direction.
  • the fixed holding member 122 and the movable holding member 123 are formed with arc-shaped holding slits on the inner surface, and the cylinder flange 213 of the drug solution syringe 200 is engaged therewith.
  • a piston drive mechanism 116 is mounted on the rear portion of the injection head 110.
  • the piston driving mechanism 116 holds the piston flange 222 of the chemical syringe 200 and slides it back and forth.
  • the piston drive mechanism 116 has a drive motor 117 such as an AC (Alternating Current) motor as a drive source, and the piston member 220 is slid by a ball screw mechanism (not shown) or the like. Move.
  • AC Alternating Current
  • the piston drive mechanism 116 also includes a load cell 118.
  • the load cell 118 detects the pressure that presses the piston member 220.
  • a long and narrow metal frame (not shown) is disposed on the left and right sides of the head housing 113, and the piston drive mechanism 116 and the main body holding member 114 are connected by the metal frame.
  • the chemical injection device 100 includes, for example, an RFID reader 130 formed as a chip component having a reader antenna (not shown) mounted on the surface thereof. As shown in FIG. 1, the RFID reader 130 is disposed on the lower surface of the main body holding member 114 so that the reader antenna is positioned on the lower side.
  • the chemical injection device 100 of this embodiment has an antenna sheet 131.
  • the antenna sheet 131 has a structure corresponding to the RFID tag 230 from which the circuit chip 232 is omitted. That is, the antenna sheet 131 is formed as an off-the-shelf product together with an RFID tag 230 in which a planar loop antenna is formed into a slender shape with printed wiring on a slender resin sheet.
  • the antenna sheet 131 and the RFID tag 230 are formed in a substantially rectangular shape of 18 mm ⁇ 50 mm, for example, and include an MM tag (product name) that performs wireless communication at a frequency of 13.56 MHz.
  • the main body holding member 114 has the holding recess 115. From the outer surface (lower surface) to the inner surface (bottom surface), a horizontally long through-hole 133 that penetrates the holding recess 115 in the thickness direction is formed. The antenna sheet 131 is passed through the through hole 133.
  • One end located above the through hole 133 of the antenna sheet 131 is bent backward, and is disposed on the bottom surface of the holding recess 115 via a ferrite sheet 135 that is a sheet-like high-permeability ferromagnetic material. Has been. For this reason, when the chemical syringe 200 is properly attached to the force injection head 110, which will be described in detail later, one end of the antenna sheet 131 is placed at a position where the RFID tag 230 is parallelly opposed and well electromagnetically coupled. Arranged! RU
  • the other end of the antenna sheet 131 located below the through hole 133 is bent forward and disposed on the lower surface of the RFID reader 130. Note that, as described above, since the reader antenna of the RFID reader 130 is located on the lower side, the reader antenna and the other end of the antenna sheet 131 face each other in parallel and are well electromagnetically coupled. .
  • FIG. 1 is a schematic diagram, and thus the force by which the ferrite sheet 135 and the antenna sheet 131 located on the bottom surface of the holding recess 115 of the main body holding member 114 protrude is actually the ferrite sheet 135 and the antenna sheet 131.
  • the thickness of this is negligible and does not obstruct the mounting of the chemical syringe 200 in the holding recess 115.
  • the injection control unit 101 connected to the injection head 110 having the structure as described above by the communication cable 102 has a built-in computer unit 140 as shown in FIG.
  • the imaging control unit 302 is also connected by wire via a communication network 304.
  • the injection control unit 101 includes an operation panel 103, a liquid crystal display 104 as a display device, a speaker unit 105, and the like arranged on the front surface of the main body housing 106, and is a separate controller unit. 107 is wired with connection cable 108.
  • the computer unit 140 is a so-called one-chip microcomputer, which includes a CPU (Central Processing Unit) 141, a ROM (Read Only Memory) 142, and a RAM (Random Access). Memory) 143, l / F (Interface) 144, and the like.
  • CPU Central Processing Unit
  • ROM Read Only Memory
  • RAM Random Access
  • Memory Memory
  • l / F Interface
  • an appropriate computer program is mounted on the information storage medium such as the ROM 142 by using firmware or the like, and the CPU 141 executes various processing operations corresponding to the computer program.
  • the computer unit 140 operates corresponding to the computer program implemented as described above, whereby the operation control means 150 is logically operated as shown in FIG.
  • the operation control means 150 includes a data storage means 151, a data collating means 152, a warning output means 153, a data storage means 154, a data holding means 156, a display control means 157, and an injection control means 158.
  • Etc. have various means logically.
  • the operation control means 150 corresponds to a function in which the CPU 141 executes a predetermined operation corresponding to the computer program installed in the ROM 142 or the like and the recording data wirelessly received from the R FID tag 230.
  • the data storage unit 151 corresponds to a storage area of the RAM 143 that the CPU 141 recognizes data, and stores predetermined confirmation conditions.
  • the data collating means 152 collates the stored confirmation conditions with the record data received wirelessly from the RFID tag 230.
  • the warning output means 153 outputs a confirmation warning corresponding to the collation result.
  • identification data of the usable chemical syringe 200 is registered as a confirmation condition in the RAM 143, and the RFID reader 130 wirelessly receives the recording data from the RFID tag 230 of the chemical syringe 200. Then, the wirelessly received identification data of the chemical syringe 200 is collated with the identification data registered in the RAM 143.
  • the RAM 143 holds the current date and time updated daily as a confirmation condition, and when the expiration date is received wirelessly from the RFID tag 230 of the chemical syringe 200, the expiration date and the current date and time are collated. The If the current date and time exceeds the expiration date, "This product Will expire after the expiration date. Guidance messages such as “Use a new U! Product!” Are displayed on the LCD 104 as a confirmation warning and also output by the speaker unit 105.
  • the serial number of each individual is also recorded in the RFID tag 230, so the data storage means 154 is attached to the injection head 110 and the injection operation is executed.
  • the data collating unit 152 collates the stored manufacturing number with the manufacturing number wirelessly received from the RFID tag 230. If the matched serial numbers match, the warning output means 153 will check the guidance message such as “This prefilled syringe has been used in the past. Please use a new product! And the speaker unit 105 outputs sound.
  • the data holding unit 156 holds the recording data wirelessly received from the RFID tag 230.
  • the display control means 157 displays the stored recording data on the liquid crystal display 104.
  • the injection control means 158 controls the operation of the piston drive mechanism 116 in accordance with the stored recording data.
  • the RFID tag 230 of the chemical syringe 200 includes data such as the name, pressure resistance, and capacity of the chemical syringe 200, and the name, components, and consumption of the chemical solution filled in the chemical syringe 200. Since data such as a time limit is recorded, the recorded data is temporarily stored in the RAM 143 and displayed on the liquid crystal display 104.
  • control data of the piston drive mechanism 116 is recorded in the RFID tag 230 of the chemical syringe 200
  • the control data is stored in the RAM 143.
  • the CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the held control data. For example, if a variable pattern that changes the injection speed of the contrast agent over time is recorded in the RFID tag 230 of the chemical syringe 200, the CPU 141 changes the operating speed of the piston drive mechanism 116 over time corresponding to the variable pattern. Change.
  • the CPU 141 holds the RAM 141 corresponding to the detected pressure of the load cell 118.
  • the operation of the piston drive mechanism 116 is controlled so as not to exceed the set pressure resistance.
  • the CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the volume held in the RAM 143. .
  • Various means of the chemical injection device 100 as described above are powers that are realized by using hardware such as the liquid crystal display 104 as necessary.
  • the main means are resources stored in an information storage medium such as the ROM 142 and the like. This is realized by the function of the CPU 141 which is hardware corresponding to the computer program.
  • Such a computer program is, for example, when the recording data is received wirelessly from the RFID tag 230 by the RFID reader 130, and the confirmation condition stored in the RAM 143 or the like and the recording data received wirelessly from the RFID tag 230.
  • a confirmation warning is output on the display of the liquid crystal display 104, etc.
  • the manufacturing number of the chemical syringe 200 that has been installed and the injection operation has been performed is stored in the RAM 143, etc.
  • the stored serial number and the serial number received wirelessly from the RFID tag 230 are collated, and a confirmation warning is output on the LCD 104 according to the collation result.
  • the recording data received wirelessly from the 230 is stored in the RAM 143 or the like, the stored recording data is displayed on the liquid crystal display 104, and the stored recording data is stored. It is stored in an information storage medium such as the RAM 143 as software for causing the CPU 141 to execute processing operations such as controlling the operation of the piston drive mechanism 116 corresponding to the data.
  • the injection head 110 of the chemical injection device 100 is arranged and used in the vicinity of the imaging unit 301 of the CT scanner 300.
  • a chemical syringe 200 is prepared.
  • the operator opens the movable holding member 123 of the injection head 110 and attaches the drug solution syringe 200 to the holding recess 115 so that the cylinder flange 213 is inserted therein.
  • the operator closes the movable holding member 123.
  • the chemical syringe 200 is affixed to the cylinder body 211, such as a sticker. Since the vertical direction is specified by the operator, when attaching the chemical syringe 200, as shown in FIG. 1 and FIG. 8 (b), the operator must properly place the chemical syringe with the RFID tag 230 positioned below. 200 is attached to the chemical injection device 100.
  • the antenna sheet 131 relays wireless communication between the RFID tag 230 and the RFID reader 130, and the RFID The tag 230 and the RFID reader 130 can communicate wirelessly satisfactorily.
  • step Sl the computer unit 140 determines whether or not the received data matches the confirmation condition registered in the RAM 143 (step S2).
  • the confirmation condition identification data of the usable drug solution syringe 200 is registered. Therefore, if the identification data received wirelessly from the RFID tag 230 is not registered as a confirmation condition, ⁇ This product is not registered as a usable syringe, please confirm that it can be used. '' Are displayed on the liquid crystal display 104 as confirmation warnings and are also output by the speaker unit 105 (step S3).
  • step S3 Guidance messages such as “This syringe has been used in the past. Please use a new product” will be output on the LCD display 104 and the speaker unit 105 as confirmation warnings if the matched serial numbers match. Therefore (step S3), it is possible to easily and reliably prevent medical mistakes and the like in which the chemical syringe 200 that should be discarded after one use is used many times.
  • the RFID tag 230 stores various data to be displayed and various data not to be displayed, for example, whether or not each of the various data is to be displayed. Is set with a binary flag, and the chemical injection device 100 displays an appropriate part of the recording data force received wirelessly from the RFID tag 230.
  • the recording data received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100 includes "pressure resistance”, “capacity”, and "variable pattern that changes the injection speed of the contrast medium over time”. If the control data is included, the control data is set in the RAM 143 of the converter unit 140 (step S7). If the control data is set in the record data received wirelessly from the RFID tag 230 !, the default control data is set.
  • step S8 transmits the start of work to the CT scanner 300 (step S11).
  • the CT scanner 300 that has received the work start data from the chemical injection device 100 in this way (step T2) returns the work start to the chemical injection device 100 and executes the imaging operation. (Step ⁇ 8). For this reason, in the chemical injection system 1000 of this embodiment, the imaging of the CT scanner 300 follows the chemical injection of the chemical injection device 100.
  • the CT scanner 300 Even when the start of imaging is input (step Tl), the chemical injection of the chemical injection device 100 follows the imaging of the CT scanner 300 (steps T4, T6 ⁇ , S9, S18 ⁇ ). Therefore, in the chemical injection system 1000 of this embodiment, the contrast medium is injected at an accurate timing. A fluoroscopic image can be taken at an appropriate timing.
  • step S18 when a series of operations of chemical injection is performed (from step S18), the injection start force elapsed time is measured (step S18). S19), the operation of the piston drive mechanism 116 is controlled in real time in accordance with the elapsed time and the control data wirelessly received from the RFID tag 230 (step S22).
  • the chemical injection device 100 of the present embodiment for example, when a variable pattern that changes the injection speed of the contrast agent over time is recorded on the RFID tag 230 of the chemical syringe 200, it corresponds to the variable pattern.
  • the operating speed of the piston drive mechanism 116 is changed over time.
  • the piston drive mechanism 116 when the piston drive mechanism 116 is driven as described above, the stress detected by the load cell 118 is received in real time by the computer unit 140 (step S20). Then, the injection pressure of the chemical solution is calculated from the stress detected by the load cell 118 corresponding to the viscosity of the chemical solution wirelessly received from the RFID tag 230 and the inner diameter of the cylinder member 210 (step S21). The operation of the piston drive mechanism 116 is controlled in real time so as to satisfy the pressure range wirelessly received from the tag 230 (step S22).
  • step S23 If the injection pressure becomes an abnormal pressure, a confirmation warning is output and the injection operation is forcibly stopped (step S23), so that it is possible to prevent a medical error in which the drug solution is injected with an abnormal pressure.
  • various data such as the inner diameter of the cylinder member 210 and the viscosity of the chemical solution are required in addition to the stress pressing the piston member 220 of the chemical solution syringe 200. Become. However, such various kinds of data are input to the chemical solution injector 100 by the RFID tag 230. For this reason, the chemical injection device 100 can accurately detect the injection pressure for each chemical solution for each chemical solution syringe 200 without requiring the cumbersome work of manually inputting various data into the chemical solution injection device 100. it can.
  • the RFID tag 230 does not face one end of the antenna sheet 131 in parallel. In this case, since the RFID tag 230 and one end of the antenna sheet 131 are not electromagnetically coupled, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly (step S1).
  • the injection operation is started in a state where the cylinder flange 213 is held by the flat portion 215 by the flange holding member 121, and the cylinder member 211 is destroyed. There is no such thing. Further, even if the chemical syringe 200 is mounted on the injection head 110 with the flat portion 215 of the cylinder flange 213 positioned vertically, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly if the chemical syringe 200 is upside down. (Step SI) The injection operation is not started when the chemical syringe 200 is upside down.
  • step S18 the RFID tag 230 is always detected by the RFID reader 130 (step S18). If the above detection is interrupted before completion of the injection operation (step S32) (step S18), the injection operation by the piston drive mechanism 116 is stopped (step S28).
  • a guidance message such as "Syringe omission detected-Please confirm the syringe installation" is displayed on the LCD 104 as a confirmation warning and voice output is output from the force unit 105.
  • Step S26 abnormal occurrence and injection stop are transmitted to CT scanner 300 (Steps S25, S28).
  • step T10 when the CT scanner 300 receives an error occurrence data (step T10), the error occurrence is output as a confirmation warning on a guidance display or the like (step T16), and when an operation stop is received (step T13). ), The imaging operation is stopped (step ⁇ 18).
  • the chemical solution syringe 200 is appropriately held, and the chemical solution injection can be automatically prevented from being executed in a state, and the chemical solution injection is performed during the chemical solution injection. Even when the syringe 200 has fallen out of its proper position force, the injection of the chemical solution can be automatically stopped.
  • the mechanism for detecting appropriate attachment of the chemical syringe 200 is the RFID tag 230 and the R FID reader 130 for transferring various data from the chemical syringe 200 to the chemical injection device 100 in this manner. Therefore, it is possible to detect the appropriate mounting of the chemical syringe 200 with a simple structure without requiring a dedicated sensor mechanism or the like.
  • the chemical injection device 100 and the CT scanner 300 detect the occurrence of abnormality in the above-mentioned preparation completion state (steps S10 and T3), or detect the occurrence of abnormality during the operation execution. Even so (Step S23, ⁇ 9), the abnormality is output (Step S26, ⁇ 16), and the operation is stopped (Step S28, ⁇ 18).
  • step S25, ⁇ 15 the other side that has received this data (step T10, S24) also outputs the abnormality occurrence (step T16).
  • step S26 the other side that has received the data (steps T13 and S31) executes the operation stop (step S21). T18, S28).
  • step S29, Tl l Even when an operation stop is input to one side (step S29, Tl l), the operation stop is executed (step S28, ⁇ 18) and also sent to the other (step S27). , ⁇ 17) On the other side of receiving the data (steps T13 and S31), the operation is stopped (steps T18 and S28).
  • step S32, T14 When the operation completion is detected on one side (steps S32, T14), the operation end is executed (step S33, ⁇ 19), and the operation end is transmitted to the other side ( In step S34, ⁇ 20), on the other side of receiving the data (step T12, S31), the operation stop is executed (step T18, S28).
  • step S33, S28 when the injection operation ends normally or abnormally as described above (steps S33, S28), the identification data wirelessly received from the RFID tag 230 of the chemical syringe 200 is new. Is registered in the RAM 143 as the confirmation condition (step S36).
  • the chemical injection device 100 of this embodiment is equipped with the RFID reader 130 on the existing injection head 110 with minimal modifications, and this RFID reader 130 is wirelessly communicated with the RFID tag 230 of the chemical syringe 200.
  • the existing antenna sheet 131 can be used.
  • the productivity of the chemical injection device 100 is good. This will be described below.
  • the main body support member 114 that supports the flange holding member 121 is formed of a metal such as an aluminum alloy because sufficient strength is required.
  • a recess is formed in the bottom surface of the holding recess 115 of the main body support member 114, and a reader antenna is provided there. It can be assumed that the RFID reader 130 is arranged so as to be located on the upper surface (not shown).
  • the metal main body support member 114 is positioned in the vicinity of the reader antenna of the RFID reader 130, and the main body support member 114 hinders wireless communication between the RFID reader 130 and the RFID tag 230. Will be.
  • the reader antenna force of the R FID reader 130 is also formed with a large recess so that the main body support member 114 is sufficiently separated, or the main body support member 114 is made of high-strength grease. It can be assumed to form (both not shown). However, this requires a major modification of the existing chemical injection device 100.
  • the RFID reader 130 is arranged on the lower surface of the main body support member 114 with the reader antenna on the lower side, the reader antenna is supported on the main body depending on the thickness of the RFID reader 130.
  • the lower surface force of the member 114 is separated, and the metal main body support member 114 can be prevented from affecting the reader antenna.
  • the RFID reader 130 is positioned below the metal main body support member 114,
  • the RFID tag 230 is disposed on the upper side of the main body support member 114, the RFID tag 230 and the RFI
  • one end of the antenna sheet 131 is arranged at a position facing the RFID tag 230 above the main body support member 114 and the other end is the main body support member 11.
  • RFID reader 13 by attaching it to the reader antenna of RFID reader 130 on the lower side of 4
  • the RFID tag 230 can be electromagnetically coupled well.
  • the antenna sheet 131 is an off-the-shelf product that is mass-produced together with the RFID tag 230, and the modification of the main body support member 114 only forms the slit-shaped through hole 133. Productivity is good.
  • the antenna sheet facing the RFID tag 230 One end force of 131 Since the ferrite sheet 135 is arranged on the surface of the main body support member 114, the electromagnetic field below the antenna sheet 131 passes through the ferrite sheet 135, and the RFID tag 230 and the antenna sheet 131 Electromagnetic coupling with the metal body support member 114 is not hindered.
  • the tag antenna 233 of the RFID tag 230 of the present embodiment is formed as an elongated loop antenna. Therefore, if the tag antenna 233 is bent in the longitudinal direction, the communication performance is extremely lowered. However, in the chemical syringe 200 of this embodiment, since the long direction of the cylinder member 210 and the RFID tag 230 are the same, the tag antenna 233 is simply bent slightly in the short direction, and the longitudinal direction. Is not curved and the communication performance is good.
  • the RFID tag 230 is a force whose communication performance is hindered even by liquid. As described above, the RF ID tag 230 needs to be attached to the cylinder member 210 in a state in which the longitudinal direction coincides with the cylinder member 210. It is difficult to place the RFID tag 230 at a position that is filled with the chemical solution.
  • the drug solution syringe 200 of this embodiment is formed with a sufficient thickness such as the cylinder member 210 force Sl. 5 mm to 2.0 mm, the RFID tag 230 attached to the surface of the syringe 200 is a cylinder. Wireless communication can be satisfactorily performed without being hindered by the chemical solution filled in the part 210.
  • the present invention is not limited to the above embodiment, and various modifications are allowed without departing from the spirit of the present invention.
  • the chemical injection device 100 in which only one chemical syringe 200 is attached to the injection head 110 is illustrated, but as shown in FIG. 13, the chemical solution in which a plurality of chemical syringes 200 are attached to the injection head 170
  • An injection device (not shown) can also be implemented.
  • the recording data detected by the RFID reader 130 from the RFID tag 230 is displayed on the liquid crystal display 104 of the injection control unit 101 separate from the injection head 110. did. However, as shown in FIG. 13, it is possible to mount a display device 171 such as a liquid crystal display on the injection head 170 and display the recorded data of the RFID tag 230 there. [0118] In this case, when the chemical syringe 200 is properly attached to the injection head 170, the recorded data is displayed on the display device 171 of the injection head 170, so that the operator can properly use the chemical syringe 200. It is possible to quickly check whether it is installed and to recognize the display data intuitively.
  • a force exemplifying that the fixed holding member 122 of the pair of left and right flange holding members 121 is separated into the left and right together with the movable holding member 123 For example, the left and right fixed holding members are integrally formed below. It is also possible that only the movable holding member 123 is separated to the left and right (not shown). Alternatively, as shown in FIG. 13, it is possible that the flange holding member is formed integrally with the main body holding member 174 only by the fixed holding member 173 that does not move.
  • a convex portion is formed on at least one of the front surface and the rear surface of the holding slit of the fixed holding member, and the convex portion is formed on a concave portion formed only on at least one lower portion of the front surface and the rear surface of the cylinder flange. It is also possible to engage (not shown). In this case, even when the flat portion of the cylinder flange is positioned up and down, the chemical syringe is not attached to the chemical injection device in the opposite state.
  • the upward force is also visually recognized through the cylinder member 210 filled with a transparent chemical solution.
  • the symbol having a predetermined shape is divided into the lower surface of the cylinder member 210 and the inner surface of the holding recess 115 of the main body holding member 114 (not shown). In this case, whether or not the chemical syringe is properly held can be confirmed by both the RFID reader 130 and the above-described design, and the force with which the cylinder member 210 is filled with the chemical solution can also be confirmed by the design. it can.
  • the RFID tag 230 is mounted on the cylinder member 210 in a state in which the longitudinal direction coincides.
  • the RFI D tag 230 can be mounted on the outer peripheral surface of the cylinder member 210 so as to be wound in the longitudinal direction! (Not shown)
  • the force exemplifying that the entire cylinder member 210 is formed with a thickness that does not inhibit the electromagnetic induction of the RFID tag 230.
  • the thickness of the cylinder member If this is not sufficient, it is possible to form only the part where the RFID tag 230 is attached to a predetermined thickness, and attach the RFID tag 230 to the cylinder member via a pedestal of grease, etc. Is possible (both not shown).
  • a ferromagnetic material such as ferrite having a high magnetic permeability is formed in a sheet shape having the same shape as that of the RFID tag 230, and the RFID tag 230 is disposed on the outer peripheral surface of the cylinder member 210 via the magnetic material. Is also possible (not shown). In this case, since the electromagnetic field on the back side of the RFID tag 230 passes through the magnetic material, the electromagnetic field can be prevented from being absorbed by the chemical solution, and the communication performance of the RFID tag 230 can be improved.
  • the upper part which is one end of the antenna sheet 131 inserted through the through hole 133 of the main body support member 114, is bent rearward and disposed at a position facing the RFID tag 230.
  • the lower end which is the other end, is bent forward and is shown in close contact with the RFID reader 130.
  • the RFID reader 130 is disposed behind the through-hole 133, and the lower portion of the antenna sheet 131 can be bent rearward to be in close contact with the RFID reader 130. It is also possible that the upper part of the PC is bent forward so as to face the RFID tag 230 (both not shown).
  • the through hole 133 is formed in the lower part of the main body holding member 114 of the chemical liquid injector 100, and the antenna sheet 131 and the RFID reader 130 are arranged.
  • the RFID tag 230 is placed at the bottom.
  • through holes 133 are formed in the left and right parts of the main body holding member 114 and the antenna sheet 131 and the RFID reader 130 are arranged, and the corresponding left part of the cylinder member 210 is arranged. It is also possible that the RFID tag 230 is arranged on the right side or the like (not shown).
  • the ferrite sheet 135 and the antenna sheet 131 having negligible thicknesses are arranged on the bottom surface of the holding recess 115 of the main body holding member 114, but for example, the holding recess 115 One end of the ferrite sheet 135 and the antenna sheet 131 can also be disposed by forming a concave hole in the bottom surface (not shown). In this case, ferrite Even when the thickness of the sheet 135 and the antenna sheet 131 cannot be ignored, the chemical syringe 200 can be satisfactorily attached to the holding recess 115 without being obstructed by the thickness.
  • the upper surface of the other end of the antenna sheet 131 is illustrated as being closely attached to the lower surface of the RFID reader 130.
  • the antenna sheet 131 It is also possible for the upper surface of the end and the lower surface of the RFID reader 130 to face each other apart (not shown).
  • the size of the chemical syringe 200 attached to the chemical injection device 100 is one.
  • the chemical syringe 200 has a plurality of sizes, and as shown in FIG. 14, a cylinder adapter 400 is prepared for each chemical syringe 200 of a size other than the maximum. Yes.
  • the chemical solution syringe 200 having the maximum size is directly attached to the chemical solution injection device 100, and the chemical solution syringe 200 having a size other than the maximum size is attached via the cylinder adapter 400. Therefore, when the cylinder adapter 400 is properly attached to the chemical injection device 100, the RFID tag 230 may be attached to the outer surface or inner surface of the cylinder adapter 400 that faces the one end of the antenna sheet 131 in parallel. Is possible.
  • the chemical liquid injector 100 can check whether both the cylinder adapter 400 and the chemical syringe 200 are properly attached. Then, by comparing the recorded data of the cylinder adapter 400 with the recorded data of the chemical syringe 200, it can be confirmed that the combination of the chemical syringe 200 and the cylinder adapter 400 is appropriate.
  • the chemical injection device 100 can use both the cylinder adapter 400 and the chemical syringe 200 with one RFID reader 130. Wireless communication with RFID tag 230.
  • the RFID tag 230 of the chemical solution syringe 200 and the antenna sheet 131 of the chemical solution injection device 100 face each other via the cylinder adapter 400. Radio between RFID tag 230 and RFID reader 130 It is preferable to form with a non-magnetic material such as rosin that does not hinder communication.
  • the chemical injection device 100 wirelessly receives the manufacturing number for each individual from the RFID tag 230 of the chemical syringe 200 used by the RFID reader 130.
  • This example illustrates that a confirmation warning is output when a new serially received serial number is stored.
  • the RFID tag 230 of the chemical syringe 200 is set as a product in which data can be added, and the chemical injection device 100 records the used state in the RFID tag 230 of the chemical syringe 200 that is installed and the injection operation is executed. It is also possible to output a confirmation warning when used is received wirelessly from the RFID tag 230 of the new chemical syringe 200.
  • chemical solution injection control data and the like are also received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100, and the chemical injection device 100 controls the chemical injection operation according to the control data.
  • the chemical injection device 100 may control the chemical injection operation corresponding to a combination of control data received wirelessly from the RFID tag 230 of the chemical syringe 200 and control data input from the operation panel 103 or the like. Is possible.
  • a time-varying pattern of chemical injection is recorded in the RFID tag 230 of the chemical syringe 200, and when an imaging region by the CT scanner 300 is input to the operation panel 103 or the like, It is also possible to adjust the variable pattern corresponding to the imaging region.
  • the chemical injection device 100 that has registered the serial number received wirelessly from the RFID tag 230 of the chemical syringe 200 after completing the injection operation ends various operations.
  • the chemical injection device 100 that has completed the injection operation and registration of the serial number data as described above detects the removal of the chemical syringe 200 by the RFID reader 130, the piston drive mechanism 116 is moved to the initial position at the end. Can be automatically retracted Noh.
  • the piston drive mechanism 116 is automatically arranged at an appropriate position by attaching / detaching the chemical syringe 200 to / from the chemical injection device 100 at an appropriate timing.
  • the convenience of the chemical injection device 100 can be further improved.
  • the force that the manufacturer assumes to record various data in the RFID tag 230 of the chemical syringe 200 is used in a medical site such as a hospital where the chemical syringe 200 is used.
  • Various data can be recorded on the RFID tag 230.
  • the piston member 220 is pushed into the cylinder member 210 of the drug solution syringe 200 in order for the drug solution injection device 100 to inject the drug solution into the subject.
  • a separate drug solution pack is extended.
  • the chemical solution injection device 100 can also fill the chemical solution syringe 200 with the chemical solution (not shown).
  • the CT scanner 300 is used as the fluoroscopic imaging apparatus, and the chemical injection device 100 injects the contrast medium for CT.
  • the MRI apparatus and the PET apparatus are used as the fluoroscopic imaging apparatus. It is also possible to inject a contrast medium for the same using a chemical injection device.
  • each part such as the chemical liquid injector 100 has been specifically described.
  • the drive source of the piston drive mechanism is formed by a direct current (DC) motor, ultrasonic motor, linear motor or solenoid! -Luminescence) It can also be formed with a display or plasma display (not shown).
  • the CPU 141 is operated corresponding to the computer program stored in the RAM 143 and the like, and various means are logically realized as various functions of the chemical solution injector 100.
  • each of these various means can be formed as unique hardware, and a part can be stored in the RAM 143 as software and a part can be formed as node hardware.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Selon l'invention, une étiquette RFID (230) est fixée à un corps cylindrique (211) d'une seringue à médicament liquide (200). Un dispositif d'injection de médicament liquide (100) comprend un élément de support du corps (114) en métal qui reçoit le corps cylindrique (211) sur sa surface supérieure. Un lecteur RFID (130) est placé sur la surface inférieure de l'élément de support du corps (114). Un évidement de retenue (115) est ménagé dans l'élément de support du corps (114) pour retenir le corps cylindrique (211), et un trou débouchant est formé dans l'évidement de retenue (115). Une plaque d'antenne (131) est insérée dans le trou débouchant. Une extrémité de la plaque d'antenne (131) est placée sur la surface intérieure de l'évidement de retenue (115), l'autre extrémité faisant face au lecteur RFID (130).
PCT/JP2007/057411 2006-04-05 2007-04-02 Système d'injection de médicament liquide Ceased WO2007116863A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008509836A JP5063591B2 (ja) 2006-04-05 2007-04-02 薬液注入システム

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006104620 2006-04-05
JP2006-104620 2006-04-05

Publications (1)

Publication Number Publication Date
WO2007116863A1 true WO2007116863A1 (fr) 2007-10-18

Family

ID=38581153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/057411 Ceased WO2007116863A1 (fr) 2006-04-05 2007-04-02 Système d'injection de médicament liquide

Country Status (2)

Country Link
JP (1) JP5063591B2 (fr)
WO (1) WO2007116863A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510868A (ja) * 2008-12-05 2012-05-17 マリンクロッド エルエルシー 誘導結合された注入器面板
JP2021506476A (ja) * 2017-12-21 2021-02-22 サノフイSanofi 受動rf変調を使用した注射デバイスの使用に関連するデータの送信
JPWO2019189449A1 (ja) * 2018-03-29 2021-03-18 テルモ株式会社 プレフィルドシリンジ、薬液投与システム及びシリンジポンプ

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001088310A1 (fr) * 2000-05-15 2001-11-22 Kensuke Asakura Procede et dispositif permettant d'enlever une partie d'une structure de beton

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509402A (ja) * 1993-05-04 1996-10-08 ゼネカ・リミテッド シリンジ及びシリンジポンプ
JPH10162260A (ja) * 1996-11-29 1998-06-19 Mitsubishi Materials Corp 盗難防止用タグ
WO2003024385A1 (fr) * 2001-09-12 2003-03-27 Terumo Kabushiki Kaisha Reservoir de medicament et dispositif d'injection de medicament integrant ledit reservoir
JP2004187849A (ja) * 2002-12-10 2004-07-08 Nemoto Kyorindo:Kk 薬液注入装置
WO2005097232A1 (fr) * 2004-04-05 2005-10-20 Nemoto Kyorindo Co., Ltd Systeme d’injection de liquide medical
JP2006034719A (ja) * 2004-07-28 2006-02-09 Terumo Corp シリンジポンプとシリンジポンプによる輸液方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509402A (ja) * 1993-05-04 1996-10-08 ゼネカ・リミテッド シリンジ及びシリンジポンプ
JPH10162260A (ja) * 1996-11-29 1998-06-19 Mitsubishi Materials Corp 盗難防止用タグ
WO2003024385A1 (fr) * 2001-09-12 2003-03-27 Terumo Kabushiki Kaisha Reservoir de medicament et dispositif d'injection de medicament integrant ledit reservoir
JP2004187849A (ja) * 2002-12-10 2004-07-08 Nemoto Kyorindo:Kk 薬液注入装置
WO2005097232A1 (fr) * 2004-04-05 2005-10-20 Nemoto Kyorindo Co., Ltd Systeme d’injection de liquide medical
JP2006034719A (ja) * 2004-07-28 2006-02-09 Terumo Corp シリンジポンプとシリンジポンプによる輸液方法

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510868A (ja) * 2008-12-05 2012-05-17 マリンクロッド エルエルシー 誘導結合された注入器面板
JP2021506476A (ja) * 2017-12-21 2021-02-22 サノフイSanofi 受動rf変調を使用した注射デバイスの使用に関連するデータの送信
CN115487380A (zh) * 2017-12-21 2022-12-20 赛诺菲 使用无源rf调制的与注射装置使用相关的数据的传输
JP7328224B2 (ja) 2017-12-21 2023-08-16 サノフイ 受動rf変調を使用した注射デバイスの使用に関連するデータの送信
US11769578B2 (en) 2017-12-21 2023-09-26 Sanofi Transmission of data associated with an injection device usage using passive RF modulation
JP2023139285A (ja) * 2017-12-21 2023-10-03 サノフイ 受動rf変調を使用した注射デバイスの使用に関連するデータの送信
JP7573076B2 (ja) 2017-12-21 2024-10-24 サノフイ 受動rf変調を使用した注射デバイスの使用に関連するデータの送信
JPWO2019189449A1 (ja) * 2018-03-29 2021-03-18 テルモ株式会社 プレフィルドシリンジ、薬液投与システム及びシリンジポンプ
EP3777924A4 (fr) * 2018-03-29 2022-05-04 TERUMO Kabushiki Kaisha Seringue pré-remplie, système d'administration de médicament liquide et pompe à seringue
JP7412330B2 (ja) 2018-03-29 2024-01-12 テルモ株式会社 シリンジポンプ

Also Published As

Publication number Publication date
JPWO2007116863A1 (ja) 2009-08-20
JP5063591B2 (ja) 2012-10-31

Similar Documents

Publication Publication Date Title
JP5063592B2 (ja) 薬液注入システム
JP5001158B2 (ja) 薬液注入システム
JP4925828B2 (ja) 薬液注入システム
JP4769197B2 (ja) 薬液注入システム
JP5802713B2 (ja) 薬液注入システム
JP4982359B2 (ja) 薬液注入システム
WO2006051856A1 (fr) Systeme d’infusion de liquides chimiques
JP5227791B2 (ja) 薬液注入装置
JP2005131007A (ja) 薬液注入システム
US20090131756A1 (en) Mechanical system
JP5063590B2 (ja) 薬液注入システム
JP5063591B2 (ja) 薬液注入システム
HK1185821A (en) Chemical liquid injection system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07740847

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008509836

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07740847

Country of ref document: EP

Kind code of ref document: A1